
Did Medtronic’s (MDT) Arrhythmia Wins and Surgical Robotics Milestone Just Shift Its Investment Narrative?
In late April 2026, Medtronic reported progress across its Affera cardiac arrhythmia portfolio, including promising ventricular tachycardia and atrial fibrillation data, an FDA Breakthrough Device Designation for the Sphere-9 catheter








